A. Kohls
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Estrogen and related hormone effects, Advanced Breast Cancer Therapies
Most-Cited Works
- → De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel(2017)167 cited
- → Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44–GeparQuinto)(2014)137 cited
- → Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results(2017)130 cited
- → Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer(2006)53 cited
- → Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study(2018)45 cited
- → Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients(2017)44 cited
- → Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study(2016)28 cited
- → Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer(2019)20 cited
- → A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes(2004)19 cited
- → Increased Incidence of Cervical Intraepithelial Neoplasia in Young Women in the Mitte District, Berlin, Germany(1999)18 cited